Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Pembrolizumab and loss of patent?Neupro patch generic?Entresto generic europe?Elinjec injection vs venofer injection?Inqovi clinical trial?
See the DrugPatentWatch profile for keytruda
Keytruda was first approved for use in the United States in September 2014. [1]
Keytruda’s initial approval timing varied by country and indication, but U.S. approval in 2014 is the widely cited release date for first market availability. [1]
Keytruda is marketed by Merck (also known as Merck & Co., Inc.). [1]
[1] https://www.drugpatentwatch.com/blog/keytruda-pembrolizumab-first-approved-for-use-in-the-u-s-in-2014/
Other Questions About Keytruda :